Jianai exists to solve the Valley of Death in life sciences

Life sciences teams have always worked with extraordinary rigour. But the systems supporting that work haven't kept pace.

When Jianai was developed in Australia in 2025, the founding team had spent years watching brilliant researchers lose months to administrative overhead, data silos, and disconnected workflows. The tools existed, they just didn't talk to each other, and none of them understood the domain deeply enough to actually help.

We built Jianai to be different. Not another project management tool with a life sciences skin. A genuinely intelligent platform, developed in conjunction with researchers, one that understands the language of development stages, regulatory requirements, and institutional collaboration, and brings structure, continuity, and AI-powered intelligence to the teams doing the work.

Today, Jianai is leading research institutions and companies in Australia and internationally, with partnerships spanning universities, research institutes, and medtech innovators.

Our Mission

Guided by 冈爱 — universal care for all — Jianai exists to solve the Valley of Death in life sciences. We build the secure AI infrastructure that connects discovery to impact, transforming decades of institutional knowledge into breakthroughs that reach patients — regardless of geography, resources, or scale.

Building momentum across research, regulation and AI

Jianai is being shaped alongside researchers, institutions and healthcare innovators to create trusted AI infrastructure for life sciences. From early institutional partnerships to active alpha testing, the platform is rapidly evolving through real-world collaboration and feedback

17+
Institutional engagements
5
Target jurisdictions
4
Live MoUs / Agreements
50+
Active alpha test users

The Jianai journey

From global medical product foundations to AI-native life sciences infrastructure.

2013

First international medical procurement operations established

Supporting hospitals and healthcare providers with medical product sourcing and cross-border supply coordination throughout Asia-Pacific.

2020

Global medical supply and market operations expanded

Medical products supplied across USA, Australia, Asia and international markets, building deep operational understanding of healthcare systems and regulatory complexity.

2023

Jianai platform vision initiated

Early AI-powered systems developed to transform fragmented medical innovation and regulatory workflows into a unified intelligent platform.

August 2025

Provisional patent filed for AI infrastructure platform

Patent filing covering Jianai’s sovereign data architecture, multi-jurisdiction regulatory intelligence systems, and AI-powered research workflows.

December 2025

Alpha platform launched for life sciences innovation

Initial alpha release launched with multiple pilot organisations and early institutional users to validate AI-assisted research and commercialisation workflows.

First institutional partnerships established

Early onboarding and collaboration with research and medical institutions including Florey Institute, University of Melbourne, and Imperial College of London.

May 2026

Secure infrastructure and compliance framework completed

Deployment of enterprise-grade infrastructure and security architecture designed for sensitive healthcare and research environments.

Tagline

Meet the team building the future of life sciences infrastructure

The Jianai team brings together expertise in life sciences, enterprise software, AI infrastructure, and regulated environments. We're headquartered in Melbourne, Australia, and work with partners and institutions globally.

Nigel Blair
Founder & CEO

25+ years cross-border executive leadership across life sciences, AI, infrastructure, risk & ESG.

Oscar Rosero
Chief Operating Officer

25-year Fortune 500 technology executive with deep Asia-Pacific and global delivery experience.

Grant Farrelly
Chief Product Officer

20+ years' product and design leadership for global Fortune 500 brands and high-growth startups.

Matt Rose
Chief Technology Officer

15+ years building digital health and technology platforms from early-stage to clinical validation.

Sandy Aitken
Fractional CTO (IT)

Senior Director AI & Technology. Former senior partner at three of the world's largest consulting firms.

John (Jiqiang) Chen
AI Research & Engineering

Applied AI specialist. Bilingual English & Chinese — key asset for East-West institutional data strategy.

Join us on the journey

We’re building a next-generation AI platform for life sciences and regulated industries. As Jianai grows, we’ll be looking for curious, mission-driven people with experience in life sciences across product, engineering, research and commercial roles.

See how Jianai supports secure, compliant innovation